CMC adds capacity at Denmark biologics site
Contract manufacturer CMC Biologics has ramped-up bioreactor capacity to meet demand for biologic drugs for Phase III clinical trials and beyond.
Archives for September 12, 2011
SSB and GE sign patent licensing deal for biomanufacturing techs
Sartorius Stedium Biotech (SSB) and GE Healthcare Life Sciences say new cross licensing deal will aid development of their respective biomanufacturing tech offerings.
Strategic deals, biotech return to boost CROs’ biz in ‘12
CRO performance across late stage, Phase I and central laboratories should improve in 2012 as strategic deals develop and smaller clients return, an analyst said.
Patheon plans facility exits & capability cuts to improve biz
Patheon is exiting semi-solids, clinical packaging and cutting facilities in response to ‘poor historical performance’.